California CBD maker Medterra has elevated its managing director for international operations to CEO.
Gregory Reeder replaces founding CEO Jay Hartenbach, who will remain chairman of the board and transition to chief innovation officer.
The company noted Reeder’s experience with major CPG brands and pharmaceuticals in its move.
Medterra said Reeder’s is “ideally suited as the company transitions and scales its business beyond CBD and into broader holistic health and wellness products.”
Before joining Medterra, Reeder was Pfizer’s global wellness lead of consumer healthcare. He started his career in product development and brand management at Procter & Gamble in Cincinnati, Ohio.
Medterra is based in Irvine and is privately held.